Clinical Trials in Baltimore

Showing 6541-6560 of 17,842 trials

CAPABLE Care Partner Pilot Study

NCT05670639

This is a small-scale multi-site pilot of a supplemental enhancement called "Care Partner" to the evidence-based CAPABLE program that will involve up to 60 individuals (30 care partners and older adult dyads) and 30 professional staff in organizations currently licensed to provide CAPABLE. This is a qualitative study of a convenience sample of individuals.

AgingCaregiver Burden

Johns Hopkins University64 participantsStarted Jan 2023

Baltimore, Maryland, United States

COMPLETEDNA< 1 mile

Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes

NCT02222909

Project CONNECT ("Community-based Organizations Neighborhood Network: Enhancing Capacity Together") is a randomized controlled trial that involves 22 community-based organizations (CBOs) located in Baltimore, MD. Half of these organizations were randomly assigned to the intervention group using a constrained cluster randomization process. The remaining 11 are a part of the control intervention group. The intervention is a co-developed set of IT tools hypothesized to improve the connections among intervention CBOs, Johns Hopkins health care facilities and CBO clients.

DiabetesCardiovascular DiseaseSubstance Abuse Disorder+1 more

Johns Hopkins Bloomberg School of Public Health6,767 participantsStarted Apr 2014

Baltimore, Maryland, United States

TERMINATEDPhase 213 miles

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

NCT04461600

The current study is designed to evaluate the efficacy and safety of AL101 monotherapy in subjects with Notch-activated recurrent or metastatic TNBC; Notch activation will be determined by a Next Generation Sequencing (NGS) test.

Triple Negative Breast Cancer

Ayala Pharmaceuticals, Inc,18 participantsStarted Aug 2020

Gilbert, Arizona, United States • Phoenix, Arizona, United States • San Francisco, California, United States +26 more locations

CAPABLE Care Partner Pilot Study

Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

Find Trials by Condition in Baltimore

A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

Improving Tobacco Treatment Rates for Outpatient Cancer Patients Who Smoke

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

Registry of CytoSorb Therapy in COVID-19 ICU Patients

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Practice of Acceptance, Awareness, and Compassion in Caregiving (PAACC)

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

Lung EpiCheck Biomarkers Development Study

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis